GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 887 filers reported holding GLAXOSMITHKLINE PLC in Q4 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,677,000 | +11.6% | 61,500 | +11.7% | 0.30% | +27.2% |
| Q1 2022 | $2,398,000 | -0.5% | 55,065 | +0.7% | 0.23% | +0.9% |
| Q4 2021 | $2,410,000 | +22.6% | 54,661 | +6.3% | 0.23% | +12.7% |
| Q3 2021 | $1,965,000 | +1.4% | 51,420 | +5.7% | 0.20% | -0.5% |
| Q2 2021 | $1,938,000 | +20.9% | 48,651 | +15.0% | 0.20% | -31.4% |
| Q1 2021 | $1,603,000 | +8.2% | 42,293 | +5.1% | 0.30% | +54.1% |
| Q4 2020 | $1,481,000 | +1.9% | 40,242 | +4.2% | 0.19% | -11.4% |
| Q3 2020 | $1,453,000 | -16.0% | 38,611 | -9.0% | 0.22% | -18.3% |
| Q2 2020 | $1,730,000 | -51.3% | 42,414 | -49.0% | 0.27% | -9.5% |
| Q1 2020 | $3,550,000 | +81.0% | 83,176 | +99.3% | 0.30% | -2.3% |
| Q4 2019 | $1,961,000 | +10.5% | 41,733 | +0.3% | 0.30% | +2.4% |
| Q3 2019 | $1,775,000 | +5.5% | 41,588 | -1.1% | 0.30% | +1.7% |
| Q2 2019 | $1,683,000 | -0.1% | 42,060 | +4.4% | 0.29% | -6.4% |
| Q1 2019 | $1,684,000 | +16.6% | 40,290 | +6.6% | 0.31% | +5.1% |
| Q4 2018 | $1,444,000 | -8.6% | 37,780 | -4.0% | 0.30% | +17.0% |
| Q3 2018 | $1,580,000 | +3.5% | 39,345 | +3.8% | 0.25% | -3.8% |
| Q2 2018 | $1,527,000 | +11.0% | 37,895 | +7.6% | 0.26% | +7.3% |
| Q1 2018 | $1,376,000 | +26.8% | 35,229 | +15.2% | 0.24% | +20.7% |
| Q4 2017 | $1,085,000 | -42.8% | 30,591 | -34.5% | 0.20% | -35.6% |
| Q3 2017 | $1,898,000 | -8.1% | 46,728 | -2.4% | 0.32% | -16.7% |
| Q2 2017 | $2,066,000 | +15.4% | 47,901 | +12.8% | 0.38% | +6.2% |
| Q1 2017 | $1,790,000 | +30.8% | 42,454 | +34.4% | 0.36% | -1.1% |
| Q2 2016 | $1,368,000 | +66.0% | 31,578 | +55.4% | 0.36% | +44.6% |
| Q1 2016 | $824,000 | +7.7% | 20,326 | +7.2% | 0.25% | -8.1% |
| Q4 2015 | $765,000 | -6.8% | 18,962 | -11.3% | 0.27% | -9.7% |
| Q3 2015 | $821,000 | -6.9% | 21,373 | +0.9% | 0.30% | -1.6% |
| Q2 2015 | $882,000 | -6.4% | 21,178 | +3.7% | 0.30% | -5.6% |
| Q1 2015 | $942,000 | +6.4% | 20,417 | -1.4% | 0.32% | +2.2% |
| Q4 2014 | $885,000 | – | 20,706 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |